![](/images/ico/ico_close.png)
![](/images/ico/ico3.png)
Period of time: 2013年6期
Publisher: Informa Healthcare
Founded in: 2001
Total resources: 4
ISSN: 1473-7167
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6
Menu
![](/images/ico/ico5.png)
A reference pricing system for Ireland
By Usher Cara,Barry Michael in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
By Bounthavong Mark,Hsu Donald I in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia
By Rofail Pierre,Tadros Mariam,Ywakim Riham,Tadrous Mina,Krug Allison,Cosler Leon E in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
The changing role of economic evaluation in valuing medical technologies
By Rotter Jason S,Foerster Douglas,Bridges John FP in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
Delivering cost-effective care for COPD in the USA: recent progress and current challenges
By Breunig Ian M,Shaya Fadia T,Scharf Steven M in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
Combating pediatric obesity in Germany: the role of economic findings in informing policy
By John Jürgen,Teuner Christina M in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
By Hedman Erik,Ljótsson Brjánn,Lindefors Nils in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire
By Crawford Bruce,Yeung Chi-Kit,Tanaka Erika,Kraemer Matthias,Leteneux Claudia in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.![](/images/ico/ico5.png)
The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature
By Becker Russell,Dembek Carole,White Leigh Ann,Garrison Louis P in (2012)
Expert Review of Pharmacoeconomics and Outcomes Research,volume 12,issue 6 , Vol. 12, Iss. 6, 2012-12 , pp.